Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 7/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.33 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.33 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.33 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.33 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.33 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.33 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.33 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.33 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.33 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12608759 | 0.80 | ACE (0.35) | ALDH1A1HPGDKDM4EMAPTPRKDC | |
| SCHEMBL4931181 | 0.68 | CYP1A2 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL12608798 | 0.68 | PTGS2 (0.48) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL12608843 | 0.67 | CYP2B6 (0.39) | — | |
| SCHEMBL5848282 | 0.64 | KDM4E (0.50) | ALDH1A1HPGDKDM4EMAPTUSP2 | |
| SCHEMBL31573923 | 0.63 | MAOA (0.40) | ALDH1A1HPGDKDM4EMAPTHTR2A | |
| SCHEMBL805990 | 0.62 | HTR2A (0.39) | MTNR1AMTNR1BABCB11SIGMAR1USP2 | |
| SCHEMBL29599480 | 0.62 | HTR2A (0.39) | MTNR1AMTNR1BABCB11SIGMAR1USP2 | |
| SCHEMBL338965 | 0.62 | MTNR1A (0.44) | MTNR1AMTNR1BABCB11SIGMAR1USP2 | |
| SCHEMBL13259202 | 0.61 | KDM4E (0.41) | KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-8323750-B2 | Method of ultraviolet light assisted surface modification and product having a surface formed by this method | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2012-12-04 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | BEIJING WANHEXINYUAN BIOTECHNOLOGY CO., LTD. (CN) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124766-A1 | METHOD OF ULTRAVIOLET LIGHT ASSISTED SURFACE MODIFICATION AN PRODUCT HAVING A SURFACE FORMED BY THIS METHOD | XPA, CYBA, PROC | ALDH1A1 2586/4885HPGD 1384/4885KDM4E 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.